GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,378,000 | -8.9% | 56,411 | -16.8% | 0.64% | -20.3% |
| Q4 2016 | $2,611,000 | +101.5% | 67,806 | +125.7% | 0.81% | +52.5% |
| Q3 2016 | $1,296,000 | -5.5% | 30,042 | -5.1% | 0.53% | -1.1% |
| Q2 2016 | $1,371,000 | -7.5% | 31,640 | -13.4% | 0.54% | +92.1% |
| Q1 2016 | $1,482,000 | -59.5% | 36,552 | -59.7% | 0.28% | -55.5% |
| Q4 2015 | $3,659,000 | +4.0% | 90,678 | -0.9% | 0.63% | -12.4% |
| Q3 2015 | $3,518,000 | -10.3% | 91,499 | -2.8% | 0.72% | -0.4% |
| Q2 2015 | $3,922,000 | -9.7% | 94,175 | +0.1% | 0.72% | -9.4% |
| Q1 2015 | $4,342,000 | +16.1% | 94,079 | +7.5% | 0.79% | +11.8% |
| Q4 2014 | $3,739,000 | -3.8% | 87,478 | +3.5% | 0.71% | -6.0% |
| Q3 2014 | $3,885,000 | -13.5% | 84,522 | +0.7% | 0.76% | -8.4% |
| Q2 2014 | $4,489,000 | +0.2% | 83,931 | +0.1% | 0.82% | +5.2% |
| Q1 2014 | $4,482,000 | +16.1% | 83,881 | +16.1% | 0.78% | -7.1% |
| Q4 2013 | $3,859,000 | – | 72,276 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |